Mannkind (MNKD) Gross Margin (2016 - 2026)

Mannkind's (MNKD) quarterly Gross Margin came in at 91.67% in Q1 2026, down 352.0% year-on-year from 36.38% in Q1 2025, and up 4.7% on a QoQ basis from 87.56% in Q4 2025.

Mannkind (MNKD) Gross Margin (2016 - 2026) Analysis & Trends

Mannkind (MNKD) has 11 years of Gross Margin data on file, last reported at 91.67% in Q1 2026.

  • On a quarterly basis, Gross Margin fell 352.0% year-over-year to 91.67% in Q1 2026; TTM through Mar 2026 was 91.53%, a 263.0% decrease from a year earlier, with the FY2025 full-year figure at 92.32%, down 158.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 91.67%, up from 87.56% in the prior quarter.
  • Over the last five years, Gross Margin for MNKD reached as high as 134.01% in Q4 2023 and fell as low as 6.14% in Q1 2022.
  • Historically, Gross Margin has averaged 81.14% across 5 years, with a median of 91.67% in 2026.
  • On a YoY basis, Gross Margin climbed as much as 25229 bps in 2022 and fell as far as 8139 bps in 2022.
  • Year by year, Gross Margin stood at 88.68% in 2022, then soared by 51 bps to 134.01% in 2023, then sank by 30 bps to 93.74% in 2024, then dropped by 7 bps to 87.56% in 2025, then rose by 5 bps to 91.67% in 2026.
  • Per Business Quant data, the three most recent Gross Margin figures were 91.67% in Q1 2026, 87.56% in Q4 2025, and 94.52% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 88.95%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 86.85%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 91.79%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 90.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Mannkind 1.20 Bn 1.07 Bn 82.66 Mn 91.67%

Historic Data

Download Data
DateValue
Mar 31, 2026 91.67%
Dec 31, 2025 87.56%
Sep 30, 2025 94.52%
Jun 30, 2025 93.98%
Mar 31, 2025 95.19%
Dec 31, 2024 93.74%
Sep 30, 2024 95.44%
Jun 30, 2024 92.26%
Mar 31, 2024 94.24%
Dec 31, 2023 134.01%
Sep 30, 2023 73.78%
Jun 30, 2023 89.25%
Mar 31, 2023 86.39%
Dec 31, 2022 88.68%
Sep 30, 2022 58.75%
Jun 30, 2022 16.02%
Mar 31, 2022 -6.14%
Dec 31, 2021 -163.60%
Sep 30, 2021 82.84%
Jun 30, 2021 81.05%